Clinical Trial: A Study to Investigate Safety and Tolerability of NDX-3315 in Healthy Participants and Patients With Eosinophilic Esophagitis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Eosinophilic Esophagitis
Study Type: INTERVENTIONAL
Official Title: An Open-label Phase 1b Study Assessing the Safety, Tolerability and Preliminary Diagnostic Performance of a Radioactive Imaging Agent, NDX-3315, in Healthy Adult Participants and Patients With Eosinop
Brief Summary:
An open-label phase 1b study to assess the safety and exploratory diagnostic performance of the oral radiopharmaceutical agent NDX-3315 in healthy participants and patients with eosinophilic esophagitis (EoE).
Read more